Literature DB >> 7049181

Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat.

B K Park, P S Grabowski, J H Yeung, A M Breckenridge.   

Abstract

The metabolism of [14C]captopril has been investigated in vitro and in vivo in male Wistar rats. The formation of conjugates of [14C]captopril with plasma proteins was observed both in vitro and in vivo: 180 min after intravenous infusion of [14C]captopril 35 +/- 5% of total radioactivity was covalently bound to plasma proteins. The fate of [14C]captopril-plasma protein conjugates was investigated in vivo. [14C]Captopril was incubated in vitro with rat and human plasma and the resulting captopril-protein conjugates were infused into male rats. The plasma concentration of [14C]captopril-rat plasma protein conjugates declined monoexponentially with a half-life of 71.1 +/- 2.2 min. After 180 min 28 +/- 3% of the radioactivity was excreted in urine, largely as [14C]captopril-cysteine mixed disulphide (67%). Thus although captopril readily forms covalent bonds with plasma proteins the resulting conjugates dissociate in vivo. The toxicological implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049181     DOI: 10.1016/0006-2952(82)90680-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  A rat model of captopril immunogenicity.

Authors:  A L Foster; J W Coleman
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

2.  Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro.

Authors:  Daisuke Harada; Shinsuku Naito; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

3.  Investigation of the Captopril-Insulin Interaction by Mass Spectrometry and Computational Approaches Reveals that Captopril Induces Structural Changes in Insulin.

Authors:  Amrita Ghosh; Aiswarya B Pawar; Tejas Chirmade; Swaraj M Jathar; Rahul Bhambure; Durba Sengupta; Ashok P Giri; Mahesh J Kulkarni
Journal:  ACS Omega       Date:  2022-06-30

4.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

5.  Drug-specific antibodies in patients receiving captopril.

Authors:  J W Coleman; J H Yeung; D H Roberts; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

Review 6.  Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.

Authors:  K L Duchin; D N McKinstry; A I Cohen; B H Migdalof
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

7.  Covalent binding of a bucillamine derivative with albumin in sera from healthy subjects and patients with various diseases.

Authors:  R Narazaki; M Otagiri
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.